• Profile
Close

Efficacy of ledipasvir and sofosbuvir treatment of HCV infection in patients coinfected with HBV

Gastroenterology Nov 29, 2017

Liu CJ, et al. - A prospective study was conducted to investigate the efficacy of ledipasvir and sofosbuvir treatment of hepatitis C virus (HCV) infection in patients coinfected with hepatitis B virus (HBV). In 100% of patients with HCV infection who were co-infected with HBV, the combination of ledipasvir and sofosbuvir for 12 weeks produced a sustained virologic response (SVR). Most patients had an increase in the level of HBV DNA not associated with signs or symptoms.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay